Cargando…
Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016776/ https://www.ncbi.nlm.nih.gov/pubmed/14519258 http://dx.doi.org/10.3201/eid0909.020666 |
_version_ | 1782195807079890944 |
---|---|
author | Bishara, Jihad Pitlik, Silvio Samra, Zmira Levy, Itzhak Paul, Mical Leibovici, Leonard |
author_facet | Bishara, Jihad Pitlik, Silvio Samra, Zmira Levy, Itzhak Paul, Mical Leibovici, Leonard |
author_sort | Bishara, Jihad |
collection | PubMed |
description | Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections. |
format | Text |
id | pubmed-3016776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-30167762011-01-20 Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 Bishara, Jihad Pitlik, Silvio Samra, Zmira Levy, Itzhak Paul, Mical Leibovici, Leonard Emerg Infect Dis Dispatch Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections. Centers for Disease Control and Prevention 2003-09 /pmc/articles/PMC3016776/ /pubmed/14519258 http://dx.doi.org/10.3201/eid0909.020666 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Dispatch Bishara, Jihad Pitlik, Silvio Samra, Zmira Levy, Itzhak Paul, Mical Leibovici, Leonard Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 |
title | Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 |
title_full | Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 |
title_fullStr | Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 |
title_full_unstemmed | Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 |
title_short | Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 |
title_sort | co-trimoxazole–sensitive, methicillin-resistant staphylococcus aureus, israel, 1988–1997 |
topic | Dispatch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016776/ https://www.ncbi.nlm.nih.gov/pubmed/14519258 http://dx.doi.org/10.3201/eid0909.020666 |
work_keys_str_mv | AT bisharajihad cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997 AT pitliksilvio cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997 AT samrazmira cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997 AT levyitzhak cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997 AT paulmical cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997 AT leibovicileonard cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997 |